Hazem G. A. Hussein

Hazem G. A. Hussein


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2023 in Molecules
Verified
Journal Article
Open access
PDF file
TSTagyedeen H. Shoaib
Tagyedeen H. Shoaib
NANihal Abdelmoniem
Nihal Abdelmoniem
RMRua M. Mukhtar
Rua M. Mukhtar
AAAmal Th. Alqhtani
Amal Th. Alqhtani
AAAbdullah Lafaa Alalawi
Abdullah Lafaa Alalawi
Abdulrahim A. AlzainAbdulrahim A. Alzain
Abdulrahim A. Alzain
The interaction between the tumor suppressor protein p53 and its negative regulator, the MDM2 oncogenic protein, has gained significant attention in cancer drug discovery. In this study, 120 lignans reported from Ferula sinkiangensis and Justicia procumbens were assessed for docking simulations on the active pocket of the MDM2 crystal structure bound to Nutlin-3a. The docking analysis identified nine compounds with higher docking scores than the co-crystallized reference. Subsequent AMDET profiling revealed satisfactory pharmacokinetic and safety parameters for these natural products. Three compounds, namely, justin A, 6-hydroxy justicidin A, and 6′-hydroxy justicidin B, were selected for further investigation due to their strong binding affinities of −7.526 kcal/mol, −7.438 kcal/mol, and −7.240 kcal/mol, respectively, which surpassed the binding affinity of the reference inhibitor Nutlin-3a (−6.830 kcal/mol). To assess the stability and reliability of the binding of the candidate hits, a molecular dynamics simulation was performed over a duration of 100 ns. Remarkably, the thorough analysis demonstrated that all the hits exhibited stable molecular dynamics profiles. Based on their effective binding to MDM2, favorable pharmacokinetic properties, and molecular dynamics behavior, these compounds represent a promising starting point for further refinement. Nevertheless, it is essential to synthesize the suggested compounds and evaluate their activity through in vitro and in vivo experiments.

5 August 2023 in Marine Drugs
Verified
Journal Article
Open access
PDF file
SISabrin R. M. Ibrahim
Sabrin R. M. Ibrahim
SMShaimaa G. A. Mohamed
Shaimaa G. A. Mohamed
BABaiaan H. Alsaadi
Baiaan H. Alsaadi
MAMaryam M. Althubyani
Maryam M. Althubyani
ZAZainab I. Awari
Zainab I. Awari
Gamal Abd AllahGamal Abd Allah
Gamal Abd Allah
Marine-derived fungi are renowned as a source of astonishingly significant and synthetically appealing metabolites that are proven as new lead chemicals for chemical, pharmaceutical, and agricultural fields. Aspergillus sydowii is a saprotrophic, ubiquitous, and halophilic fungus that is commonly found in different marine ecosystems. This fungus can cause aspergillosis in sea fan corals leading to sea fan mortality with subsequent changes in coral community structure. Interestingly, A. sydowi is a prolific source of distinct and structurally varied metabolites such as alkaloids, xanthones, terpenes, anthraquinones, sterols, diphenyl ethers, pyrones, cyclopentenones, and polyketides with a range of bioactivities. A. sydowii has capacity to produce various enzymes with marked industrial and biotechnological potential, including α-amylases, lipases, xylanases, cellulases, keratinases, and tannases. Also, this fungus has the capacity for bioremediation as well as the biocatalysis of various chemical reactions. The current work aimed at focusing on the bright side of this fungus. In this review, published studies on isolated metabolites from A. sydowii, including their structures, biological functions, and biosynthesis, as well as the biotechnological and industrial significance of this fungus, were highlighted. More than 245 compounds were described in the current review with 134 references published within the period from 1975 to June 2023.

18 October 2023 in Metabolites
Verified
Journal Article
Open access
PDF file
TSTagyedeen H. Shoaib
Tagyedeen H. Shoaib
MAMohammed A. Almogaddam
Mohammed A. Almogaddam
YAYusra Saleh Andijani
Yusra Saleh Andijani
SSSamaher Ahmad Saib
Samaher Ahmad Saib
NANajwa mahmoud Almaghrabi
Najwa mahmoud Almaghrabi
Abdulrahim A. AlzainAbdulrahim A. Alzain
Abdulrahim A. Alzain
Cyclin-dependent kinase 5 (CDK5) plays a crucial role in various biological processes, including immune response, insulin secretion regulation, apoptosis, DNA (deoxyribonucleic acid) damage response, epithelial−mesenchymal transition (EMT), cell migration and invasion, angiogenesis, and myogenesis. Overactivation of CDK5 is associated with the initiation and progression of cancer. Inhibiting CDK5 has shown potential in suppressing cancer development. Despite advancements in CDK5-targeted inhibitor research, the range of compounds available for clinical and preclinical trials remains limited. The marine environment has emerged as a prolific source of diverse natural products with noteworthy biological activities, including anti-cancer properties. In this study, we screened a library of 47,450 marine natural compounds from the comprehensive marine natural product database (CMNPD) to assess their binding affinity with CDK5. Marine compounds demonstrating superior binding affinity compared to a reference compound were identified through high-throughput virtual screening, standard precision and extra-precision Glide docking modes. Refinement of the selected molecules involved evaluating molecular mechanics–generalized born surface area (MM/GBSA) free binding energy. The three most promising compounds, (excoecariphenol B, excoecariphenol A, and zyzzyanone B), along with the reference, exhibiting favorable binding characteristics were chosen for molecular dynamics (MD) simulations for 200 nanoseconds. These compounds demonstrated interaction stability with the target during MD simulations. The marine compounds identified in this study hold potential as effective CDK5 inhibitors and warrant subsequent experimental validation.

15 April 2024 in Archives of Microbiology
Verified
Journal Article
Closed access
PDF file
BBBayan E. bayan
Bayan E. bayan
SISabrin R. M. Ibrahim
Sabrin R. M. Ibrahim
Abdulrahim A. AlzainAbdulrahim A. Alzain
Abdulrahim A. Alzain
SMShaimaa G. A. Mohamed
Shaimaa G. A. Mohamed
HHHazem G. A. Hussein
Hazem G. A. Hussein
Gamal Abd AllahGamal Abd Allah
Gamal Abd Allah

9 April 2024 in Network Modeling Analysis in Health Informatics and Bioinformatics
Verified
Journal Article
Closed access
PDF file
MAMohammed A. Almogaddam
Mohammed A. Almogaddam
TSTagyedeen H. Shoaib
Tagyedeen H. Shoaib
SMShaimaa G. A. Mohamed
Shaimaa G. A. Mohamed
Gamal Abd AllahGamal Abd Allah
Gamal Abd Allah
SISabrin R. M. Ibrahim
Sabrin R. M. Ibrahim
Abdulrahim A. AlzainAbdulrahim A. Alzain
Abdulrahim A. Alzain

22 November 2023 in Mycological Progress
Verified
Journal Article
Closed access
PDF file
BBBayan E. bayan
Bayan E. bayan
Abdulrahim A. AlzainAbdulrahim A. Alzain
Abdulrahim A. Alzain
TSTagyedeen H. Shoaib
Tagyedeen H. Shoaib
SMShaimaa G. A. Mohamed
Shaimaa G. A. Mohamed
HHHazem G. A. Hussein
Hazem G. A. Hussein
SISabrin R. M. Ibrahim
Sabrin R. M. Ibrahim